BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29090365)

  • 1. CD56+ immune cell infiltration and MICA are decreased in breast lobules with fibrocystic changes.
    Kerekes D; Visscher DW; Hoskin TL; Radisky DC; Brahmbhatt RD; Pena A; Frost MH; Arshad M; Stallings-Mann M; Winham SJ; Murphy L; Denison L; Carter JM; Knutson KL; Degnim AC
    Breast Cancer Res Treat; 2018 Feb; 167(3):649-658. PubMed ID: 29090365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in the Immune Cell Composition in Premalignant Breast Tissue that Precede Breast Cancer Development.
    Degnim AC; Hoskin TL; Arshad M; Frost MH; Winham SJ; Brahmbhatt RA; Pena A; Carter JM; Stallings-Mann ML; Murphy LM; Miller EE; Denison LA; Vachon CM; Knutson KL; Radisky DC; Visscher DW
    Clin Cancer Res; 2017 Jul; 23(14):3945-3952. PubMed ID: 28126725
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytotoxic T cell depletion with increasing epithelial abnormality in women with benign breast disease.
    Adhikary S; Hoskin TL; Stallings-Mann ML; Arshad M; Frost MH; Winham SJ; Peña A; Lee DJ; Murphy LM; Rakoff M; Denison LA; Knutson KL; Radisky DC; Visscher DW; Degnim AC
    Breast Cancer Res Treat; 2020 Feb; 180(1):55-61. PubMed ID: 31933142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective infiltration of natural killer cells in MICA/B-positive renal cell carcinoma involves beta(2)-integrin-mediated interaction.
    Sconocchia G; Spagnoli GC; Del Principe D; Ferrone S; Anselmi M; Wongsena W; Cervelli V; Schultz-Thater E; Wyler S; Carafa V; Moch H; Terracciano L; Tornillo L
    Neoplasia; 2009 Jul; 11(7):662-71. PubMed ID: 19568411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD56 expression in breast cancer induces sensitivity to natural killer-mediated cytotoxicity by enhancing the formation of cytotoxic immunological synapse.
    Taouk G; Hussein O; Zekak M; Abouelghar A; Al-Sarraj Y; Abdelalim EM; Karam M
    Sci Rep; 2019 Jun; 9(1):8756. PubMed ID: 31217484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of MICA on high-grade invasive operable breast carcinoma.
    Madjd Z; Spendlove I; Moss R; Bevin S; Pinder SE; Watson NF; Ellis I; Durrant LG
    Cancer Immun; 2007 Oct; 7():17. PubMed ID: 17948965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HER2/HER3 signaling regulates NK cell-mediated cytotoxicity via MHC class I chain-related molecule A and B expression in human breast cancer cell lines.
    Okita R; Mougiakakos D; Ando T; Mao Y; Sarhan D; Wennerberg E; Seliger B; Lundqvist A; Mimura K; Kiessling R
    J Immunol; 2012 Mar; 188(5):2136-45. PubMed ID: 22301547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the tumor infiltrating natural killer cell (NK-TILs) count in infiltrating ductal carcinoma of breast prognostically significant?
    Rathore AS; Goel MM; Makker A; Kumar S; Srivastava AN
    Asian Pac J Cancer Prev; 2014; 15(8):3757-61. PubMed ID: 24870789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NZ28-induced inhibition of HSF1, SP1 and NF-κB triggers the loss of the natural killer cell-activating ligands MICA/B on human tumor cells.
    Schilling D; Kühnel A; Tetzlaff F; Konrad S; Multhoff G
    Cancer Immunol Immunother; 2015 May; 64(5):599-608. PubMed ID: 25854583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lobule type and subsequent breast cancer risk: results from the Nurses' Health Studies.
    Baer HJ; Collins LC; Connolly JL; Colditz GA; Schnitt SJ; Tamimi RM
    Cancer; 2009 Apr; 115(7):1404-11. PubMed ID: 19170235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NKG2D functions as an activating receptor on natural killer cells in the common marmoset (Callithrix jacchus).
    Watanabe M; Kudo Y; Kawano M; Nakayama M; Nakamura K; Kameda M; Ebara M; Sato T; Nakamura M; Omine K; Kametani Y; Suzuki R; Ogasawara K
    Int Immunol; 2014 Nov; 26(11):597-606. PubMed ID: 24860119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of changes in expression and presentation of NKG2D under influence of MICA serum factor in different stages of breast cancer.
    Roshani R; Boroujerdnia MG; Talaiezadeh AH; Khodadadi A
    Tumour Biol; 2016 May; 37(5):6953-62. PubMed ID: 26662806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble MICA-NKG2D interaction upregulates IFN-γ production by activated CD3-CD56+ NK cells: potential impact on chronic graft versus host disease.
    Boukouaci W; Al-Daccak R; Dulphy N; Lauden L; Amokrane K; Fortier C; Marzais F; Bennabi M; Peffault de Latour R; Socie G; Toubert A; Charron D; Krishnamoorthy R; Tamouza R
    Hum Immunol; 2013 Dec; 74(12):1536-41. PubMed ID: 23994587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The roles of soluble MICA in immune escape of breast tumor].
    Ye YB; Zhou ZF; Chen Q; Li JY; Chen X; Huang WW
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Sep; 24(9):904-7. PubMed ID: 18782524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptomatic Carotid Atherosclerotic Plaques Are Associated With Increased Infiltration of Natural Killer (NK) Cells and Higher Serum Levels of NK Activating Receptor Ligands.
    Bonaccorsi I; Spinelli D; Cantoni C; Barillà C; Pipitò N; De Pasquale C; Oliveri D; Cavaliere R; Carrega P; Benedetto F; Ferlazzo G
    Front Immunol; 2019; 10():1503. PubMed ID: 31354703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer.
    Bauernhofer T; Kuss I; Henderson B; Baum AS; Whiteside TL
    Eur J Immunol; 2003 Jan; 33(1):119-24. PubMed ID: 12594840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-γ production by tubulointerstitial human CD56
    Law BMP; Wilkinson R; Wang X; Kildey K; Lindner M; Rist MJ; Beagley K; Healy H; Kassianos AJ
    Kidney Int; 2017 Jul; 92(1):79-88. PubMed ID: 28396119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune cell quantitation in normal breast tissue lobules with and without lobulitis.
    Degnim AC; Brahmbhatt RD; Radisky DC; Hoskin TL; Stallings-Mann M; Laudenschlager M; Mansfield A; Frost MH; Murphy L; Knutson K; Visscher DW
    Breast Cancer Res Treat; 2014 Apr; 144(3):539-49. PubMed ID: 24596048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplicity of benign breast lesions is a risk factor for progression to breast cancer.
    Worsham MJ; Raju U; Lu M; Kapke A; Cheng J; Wolman SR
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5474-9. PubMed ID: 17875777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of anaesthetic technique on immune cell infiltration in breast cancer: a follow-up pilot analysis of a prospective, randomised, investigator-masked study.
    Desmond F; McCormack J; Mulligan N; Stokes M; Buggy DJ
    Anticancer Res; 2015 Mar; 35(3):1311-9. PubMed ID: 25750280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.